Research Antibodies & Reagents Marketing Research Report 2022

 

Dublin, July 27, 2022 (WORLD NEWSWIRE)– The “Global Research Antibodies & Reagents Market by Product (Antibodies (Type, Kind, Source, Research Location), Reagents), Technology (Western Blot, Circulation Cytometry, ELISA), Application (Proteomics, Genomics), End-user (Pharma, Biotech, CROs), and Area – Forecast to 2027” report has been contributed to ResearchAndMarkets.com’s offering.

 

The global research study antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7%.

The research antibodies and reagents market progressed owing to aspects such as increasing proteomics and genomics research study, growing need for antibodies for research study reproducibility, and increasing R&D expense in the life sciences industry.

Driven by the increasing demand for tailored medicine and structure-based drug design. It is anticipated that the international research antibodies and reagents market will witness substantial growth in the coming years.

 

On the basis of item, the reagents segment holds the greatest market share during the projection period.

On the basis of item, the research antibodies and reagents market are segmented into reagent and antibodies. In 2021 the reagent section represented the larger market share. Aspects such as increasing applications of biosciences and biotechnology within the healthcare and pharmaceutical fields is driving the marketplace.

 

On the basis of innovation, the flow cytometry segment is anticipated to register the highest CAGR during the projection duration.

On the basis of technology, the research study antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. During the forecast period the flow cytometry sector is anticipated to witness the highest growth.

Factors such as benefits of this strategy, its capability to carry out simultaneous multi-parameter analysis on single cells within a heterogeneous mixture, using high throughput in addition to technological innovations in circulation cytometry and increasing oncology research study, are driving the development of this sector.

 

On the basis of application, the proteomics sector holds the greatest market share during the forecast period.

On the basis of application, the research study antibodies and reagents market is segmented into proteomics, drug development and Genomics. In 2021, Proteomics held the biggest share of the global research study antibodies and reagents market. Factors such as increasing efficiency maps drug-protein and protein-protein interactions.

Additionally, proteomic technologies have reduced the time, cost, and resource requirements for chemical synthesis and biological screening of drugs and are highly effective. Such factors are driving the marketplace.

 

On the basis of end-user, the pharmaceutical & biotechnology section holds the highest market share during the projection duration.

The research antibodies and reagents market is divided into the pharmaceutical & biotechnology business, academic & research organizations and Contract Research study Organizations.

In 2021 the pharmaceutical & biotechnology business held the biggest share of the worldwide research study antibodies and reagents end-user market. Factors such as growing usage of research antibodies in drug advancement for the recognition and quantification of biomarkers and other strategies are driving the marketplace.

 

By Region, Asia Pacific is anticipated to sign up the greatest CAGR throughout the forecast period.

Throughout the forecast period (2022 to 2027), the Asia Pacific research antibodies and reagents market is expected to grow at the highest CAGR. Factors such as increasing research study in proteomics and genomics and growing research study funding, investments by pharmaceutical and biotechnology business, and growing awareness in the region are driving the marketplace in the region.

 

Secret Gamers.

The crucial gamers running in the research antibodies and reagents systems include Thermo Fisher Scientific, Inc. United States), Merck KGaA (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Innovation (United States), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (United States), Agilent Technologies (US), PerkinElmer (United States), Lonza (Switzerland), GenScript (China), and BioLegend (United States).

 

Premium Insights.

• Increasing R&D Expense in the Life Science Industry to Drive Market Development.
• Proteomics Accounted for the Largest Share of the Asia-Pacific Research Antibodies and Reagents Market in 2021.
• China Reveals the Highest Income Growth Opportunities During the Projection Period.
• The United States And Canada Will Continue to Dominate the Research Antibodies and Reagents Market Till 2027.
• Establishing Markets to Register a Higher Development Rate in the Forecast Duration.

 

Market Dynamics.

Motorists

• Increasing Research Study Activity and Financing for R&D.
• Growing Industry-Academia Collaboration.

 

Restraints

• Quality Concerns and an Absence of Reproducible Outcomes.

 

Opportunities

• Emerging Markets.
• Individualized Medicine and Protein Therapeutics.
• Development in Stem Cell and Neurobiology Research Study.
• Increasing Concentrate On Biomarker Discovery.
• Increasing Interest in Outsourcing.

 

Difficulties

• Expense and Time-Intensive Antibody Advancement Processes.
• Rates Pressure Faced by Popular Market Gamers.

 

Industry Trends

• Increasing Research on Therapeutic Antibodies.
• Recombinant Antibodies Supporting the Smooth Shift from in Vitro to in Vivo.
• Growing Consolidation of the Life Sciences Market for Reagents and antibodies.
• Stakeholder Analysis.

 

Strategic Benchmarking

• Effect of COVID-19 on the Research Study Antibodies and Reagents Market.

 

Supply Chain Analysis

• Innovation Analysis.
• Regulatory Analysis.

 

Companies Mentioned

• Abcam plc
• Agilent Technologies, Inc.
• Analytik Jena AG
• Atlas Antibodies
• BD
• Bio-Rad Laboratories, Inc.
• Biolegend
• Cell Signaling Technology, Inc.
• Danaher Corporation
• Dovetail Genomics
• F. Hoffmann-La Roche
• Fujirebio Diagnostics AB
• Genscript
• Illumina, Inc.
• Immunoprecise Antibodies Ltd
• Lonza
• Merck KGaA
• Omega Bio-Tek
• Perkinelmer, Inc.
• Thermo Fisher Scientific, Inc.